Corcept Therapeutics Inc (CORT)
55.96
-0.13
(-0.23%)
USD |
NASDAQ |
Nov 21, 16:00
55.96
0.00 (0.00%)
After-Hours: 16:46
Corcept Therapeutics Market Cap: 5.863B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 5.877B |
| November 19, 2024 | 5.690B |
| November 18, 2024 | 5.513B |
| November 15, 2024 | 5.430B |
| November 14, 2024 | 5.741B |
| November 13, 2024 | 5.915B |
| November 12, 2024 | 6.055B |
| November 11, 2024 | 6.188B |
| November 08, 2024 | 6.245B |
| November 07, 2024 | 5.689B |
| November 06, 2024 | 5.682B |
| November 05, 2024 | 5.463B |
| November 04, 2024 | 5.245B |
| November 01, 2024 | 4.989B |
| October 31, 2024 | 5.131B |
| October 30, 2024 | 4.913B |
| October 29, 2024 | 5.051B |
| October 28, 2024 | 5.065B |
| October 25, 2024 | 4.954B |
| October 24, 2024 | 4.950B |
| October 23, 2024 | 5.035B |
| October 22, 2024 | 5.122B |
| October 21, 2024 | 5.142B |
| October 18, 2024 | 5.209B |
| October 17, 2024 | 4.939B |
| Date | Value |
|---|---|
| October 16, 2024 | 4.949B |
| October 15, 2024 | 4.904B |
| October 14, 2024 | 4.743B |
| October 11, 2024 | 4.757B |
| October 10, 2024 | 4.738B |
| October 09, 2024 | 4.810B |
| October 08, 2024 | 4.793B |
| October 07, 2024 | 4.676B |
| October 04, 2024 | 4.757B |
| October 03, 2024 | 4.716B |
| October 02, 2024 | 4.802B |
| October 01, 2024 | 4.895B |
| September 30, 2024 | 4.846B |
| September 27, 2024 | 4.590B |
| September 26, 2024 | 4.522B |
| September 25, 2024 | 4.445B |
| September 24, 2024 | 4.598B |
| September 23, 2024 | 4.488B |
| September 20, 2024 | 4.415B |
| September 19, 2024 | 4.276B |
| September 18, 2024 | 4.417B |
| September 17, 2024 | 4.149B |
| September 16, 2024 | 4.020B |
| September 13, 2024 | 3.982B |
| September 12, 2024 | 3.731B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.159B
Minimum
Mar 16 2020
6.245B
Maximum
Nov 08 2024
2.559B
Average
2.486B
Median
May 01 2024
Market Cap Benchmarks
| Catalyst Pharmaceuticals Inc | 2.520B |
| Madrigal Pharmaceuticals Inc | 7.179B |
| ADMA Biologics Inc | 5.034B |
| Alnylam Pharmaceuticals Inc | 31.84B |
| Akebia Therapeutics Inc | 394.91M |
Market Cap Related Metrics
| PE Ratio | 44.41 |
| PS Ratio | 9.920 |
| PEG Ratio | 0.7994 |
| Price to Book Value | 9.178 |
| Price to Free Cash Flow | 43.72 |
| Price | 55.96 |
| Earnings Yield | 2.25% |
| PEGY Ratio | 0.7994 |
| Operating PE Ratio | 43.49 |
| Normalized PE Ratio | 44.41 |